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In amousemutagenesis screen,we isolatedamutant,Myshkin (Myk),
with autosomal dominant complex partial and secondarily general-
ized seizures, a greatly reduced threshold for hippocampal seizures in
vitro, posttetanic hyperexcitabilityof theCA3-CA1hippocampal path-
way, and neuronal degeneration in the hippocampus. Positional
cloning and functional analysis revealed that Myk/ mice carry a
mutation (I810N) which renders the normally expressed Na,K-
ATPase 3 isoform inactive. Total Na,K-ATPase activity was re-
duced by 42% in Myk/ brain. The epilepsy in Myk/ mice and in
vitro hyperexcitability could be prevented by delivery of additional
copies of wild-type Na,K-ATPase 3 by transgenesis, which also
rescued Na,K-ATPase activity. Our findings reveal the functional
significance of the Na,K-ATPase 3 isoform in the control of
epileptiform activity and seizure behavior.
alpha3 Na,K ATPase  BAC rescue  epilepsy  forward genetic screen 
mouse
Epilepsy is a debilitating neurological disorder characterized byrecurrent seizures triggered by excessive neuronal excitability in
the brain. At least 40–50% of all forms of epilepsy are idiopathic,
and thus have a presumed genetic origin (1). Identifying genetic and
pathophysiological pathways involved in epilepsy is critical for the
rational design of improved treatments for the one-third of epilepsy
patients who do not respond to current medications (2).
Na,K-ATPases (sodium/potassium pumps) play a seminal role in
controlling neuronal excitability by maintaining electrochemical gradi-
ents for Na and K across the plasmamembrane. Hence, it has been
hypothesized that an abnormality in Na,K-ATPase could facilitate
seizures (3–6). Indeed, partial inhibition of Na,K-ATPase activity
with cardiac glycosides has been shown to induce seizures in rats (7–9).
Furthermore, some patients with the autosomal dominant genetic
disorder familial hemiplegic migraine (FHM) type 2, caused by muta-
tion of the Na,K-ATPase 2-isoform, have a clinical history of
epileptic seizures (10). Three isoforms of the Na,K-ATPase -sub-
unit,1,2, and3, encodedbyparalogous genes (Atp1a1,Atp1a2, and
Atp1a3, respectively), are expressed in mammalian brain: 1 as the
housekeepingenzymeinavarietyofcell types,2predominantly inglial
cells in humanadults, and3 exclusively in neurons (11). The increased
epileptic propensity observed in patients with FHM, and thus the role
of the Na,K-ATPase 2-isoform in generation of seizures, has been
explained by the reduced ability of glial cells to clear the extracellular
space of K and glutamate (6). So far there has been no convincing
evidence linking the neuron specific3-isoformofNa,K-ATPase to
epilepsy. Mutations in the human ATP1A3 gene encoding 3 are
associatedwith rapid-onset dystonia-parkinsonism (RDP), but seizures
are not a typical characteristic of this disease (12)—possibly because
most knownRDPmutations are compatiblewithpartialNKAfunction
(13). The similar affinities of 2 and 3 for the Na,K-ATPase
inhibitorouabainhaveprecludedconclusivepharmacological studiesof
isoform specificity.
Here, we present amousemodel for epilepsy caused bymutation
of the Na,K-ATPase 3-isoform. We have used in vivo mu-
tagenesis with N-nitroso-N-ethylurea (ENU) (14) to generate a
mutant named Myshkin (Myk) that displays seizures and neuronal
hyperexcitability in heterozygotes (Myk/) and perinatal death in
homozygotes (Myk/Myk). The Myshkin allele contains a point
mutation in the Na,K-ATPase 3-isoform that inactivates this
enzyme and is solely responsible for complex partial and second-
arily generalized seizures in these mice.
Results and Discussion
In a screen for dominant visible phenotypes among 8-week-old
progeny of ENU mutagenized 129S1/SvImJ (129S1) males and
untreated C57BL/6J females, we found a female with a small body.
This phenotype proved to be heritable as a Mendelian autosomal
dominant trait, as 10 of 23 (43.5%) N2 progeny of this mouse and
a C57BL/6NCr (B6) male had a visibly smaller body than their
same-sex littermates (see Fig. S1). We observed that the small mice
exhibited spontaneous, recurrent convulsive seizures in the home
cage from weaning at 4 weeks of age. When bred to homozygosity,
Myk/Myk pups appeared grossly normal but died shortly after birth,
indicating that the seizure and small body phenotype ofMyk/mice
is semidominant. We localized the Myshkin allele to a nonrecom-
binant interval of chromosome 7 (Fig. 1). Sequencing of genomic
DNA and whole brain cDNA fromMyk/Myk (n  2),Myk/ (n 
2), and / (n  2) mice revealed 2 de novo mutations in the
Atp1a3 gene encoding the 3 isoform of the Na,K-ATPase,
predicted to result in amino acid substitutions Asp653Glu (D65E)
and Ile8103Asn (I810N) (Fig. 1). Each of these amino acids is
conserved across vertebrate species (Fig. 1). Both mutations ap-
peared in 107 Myk/ mice after 12 generations of backcrossing to
B6, but neither was found in 104 / littermates. Hence,Myshkin
is an allele of Atp1a3 (Atp1a3Myk).
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The functional characteristics of mutations D65E and I810N of
the Na,K-ATPase have not previously been studied in vitro or in
vivo. The double mutant D65EI810N and each point mutant
D65E and I810N were examined by transfecting COS cells (15).
Each mutant was expressed to a wild type-like level and targeted
normally to the plasma membrane (Fig. S2). The Na,K-ATPase
activities of the D65EI810N and I810N 3 mutants, but not
D65E, were too low to support growth and survival of COS cells.
Thus, I810N alone disrupts enzyme function. D65E 3 exhibited
unimpaired function with normal catalytic turnover rate and Na,
K, and ATP affinities (Fig. S2). Asp65 is located at the cytosolic
NH2 terminus, whereas Ile810 is located in the membrane (16),
where it may interact with Thr329 (Fig. S3). Disruption of this
interaction by introducing the polar asparagine at position 810
might destabilize the ion binding pocket, which is constituted by
oxygen containing residues close to Ile810 (16).
Weaned Myk/ mice exhibited spontaneous, recurrent behav-
ioral convulsions in the home cage (Fig. 2), which could also be
evoked reliably by vestibular stress. Seizures started with running
and leaping, behavioral arrest (freezing/staring), and Straub tail,
followed bywhole body clonic jerking and falling, resembling partial
complex seizures with secondary generalization (localized attack
preceding whole body convulsions). Seizures were accompanied by
salivation, and occasionally progressed to maximal tonic hindlimb
extension, which was invariably followed by death (Movie S1).
We observed freelymovingMyk/ (n 9) and/ (n 6)mice
for 30–45 min by synchronous video monitoring and electrocorti-
cographic (ECoG) recordings. Spontaneous behavioral seizures
were accompanied by classical neocortical and depth amygdala
spike-and-waves characteristic of epileptic discharges. In Myk/
mice, rhythmic vertical shaking of the cage (vestibular stress)
induced intermittent sharp waves (preictal) that increased in am-
plitude until generalized bilaterally synchronous tonic-clonic sei-
zure activity was observed (ictal), whereas no such seizure activity
was observed in/mice (Fig. 2). In 3 of 9Myk/mice, the cage
shaking induced convulsive seizures immediately (Movie S2).
Treatment with valproic acid (VPA), a broad spectrum antiepi-
leptic drug, reduced the severity of seizures exhibited by Myk/
mice after cage shaking (VPA: 0.69  0.41, Vehicle: 2.4  0.70; F
(1, 22)  4.86, P  0.039; 1–6 scale). Moreover, epilepsy in Myk/
mice could be prevented by delivery of additional copies of wild-
type Na,K-ATPase 3 by transgenesis with a bacterial artificial
chromosome (BAC) containing Atp1a3 and its promoter. BAC
transgenic mice showing a 58  6% increase in 3 protein level in
the brain (Fig. S4) were crossed with Myk/ mice to yield Myk//
BAC mice. Cage shaking did not induce seizures in Myk//BAC
Fig. 1. Positional cloning ofMyshkin. (A) Fine mapping of theMyshkinmutation on Chr 7. White squares represent 129S1:B6 heterozygous alleles and black squares
represent homozygous B6 alleles. The number of progeny inheriting each haplotype is listed on the bottom line. (B) DNA sequence traces of Atp1a3 exons 4 and 18
fromMyshkinmice and the 129S1 and B6 parental strains. Asterisks indicate the location of a T3A transversion at nucleotide 328 and a T3A transversion at nucleotide
2,562. The sequences of Atp1a3 exons 4 and 18 in the mapping strains 129S1 and B6 are identical, indicating that 328T3A and 2562 T3A are de novo mutations. (C)
EcoO109I restriction site (5-AG*GGCCT-3) generated by the 328T3A mutation in Atp1a3. A 576-bp PCR amplicon is cleaved by EcoO109I into 212-bp and 354-bp
fragments. (D) Alignment of partial 3 protein sequences of several vertebrate species (Upper) and partial Mus musculus 1, 2, and 3 protein sequences (Lower),
showing conservation of amino acids D65 (Blue text) and I810 (Red text).
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mice during ECoG recordings (Fig. 2), and no behavioral signs of
seizures after ECoG testing, nor mortality within 2 weeks, were
observed. In contrast, 5 of 6 Myk/ littermates subjected to the
same treatment showed convulsive seizures and epileptiform dis-
charges.
Combined hippocampus-entorhinal cortex slices (Fig. 3) are
useful for investigation of the mechanisms of seizure induction and
spread in the medial temporal lobe (17). Superfusion of Mg2-free
artificial cerebrospinal fluid, a treatment that over-activates
NMDA receptors (18), induced repeated synchronized ictal bursts
in CA3 and the entorhinal cortex (EC) in more than half of the
slices from Myk/ mice, whereas such bursts were only rarely
observed in / slices (Fig. 3). The remaining Myk/ slices
exhibited only brief asynchronous interictal bursts (CA3) and
negativeDC shifts (EC) similar to those characteristic of/ slices,
but the epileptiform activity appeared sooner after Mg2 removal
inMyk/ slices than in/ slices (Fig. 3). The enhanced epileptic
propensity of hippocampal-EC slices fromMyk/mice was rescued
by BAC transgenesis of additional copies of wild-type Na,K-
ATPase 3 (Fig. 3).
Hippocampal slices from Myk/ mice showed enhanced excita-
tion-spike (E-S) coupling after theta burst stimulation (TBS), as
determined by the relation between the postsynaptic population
action potential (popAP) spike and the field excitatory postsynaptic
potential (fEPSP) (Fig. 4), indicating that the CA3–CA1 hippocam-
pal pathway became hyperexcitable after physiological patterns of
high-frequency synaptic activity. Under basal conditions, this path-
way had wild type-like synaptic transmission, plasticity, and excit-
ability (Fig. S5). Over-stimulation of NMDA receptors induces
seizures (18, 19), and the observed posttetanic increase in E-S
coupling in CA1 pyramidal neurons may result from an NMDA
receptor-dependent long-term depression (LTD) of feed-forward
GABAA-mediated inhibition (19).
The neuropathology of young adult Myk/ mice showed histo-
logical sequela of seizures, such as medial temporal sclerosis and
aberrantmembranous whorls in hippocampal pyramidal neurons in
CA3 and CA1 (see SI Text, Fig. S6).
The total specific Na,K-ATPase activity of brain homogenates
(contributed by 1, 2, and 3 isoforms) showed a reduction by
42  3% in 10-week-old Myk/ mice relative to their / litter-
mates, whereas the rescuedMyk//BAC mice showed significantly
less reduction (26  3%) (Fig. 5). Neither the Na,K-ATPase
activity per active catalytic site [Myk/:7,142 349 min1 (n 15)
versus/:7,776 309 min1 (n 12)] nor the affinities for Na
and K were significantly different betweenMyk/ and / mice
(Fig. S7), suggesting that the residual 58% activity in Myk/ brain
is derived from the normal 3 enzyme encoded by the wild-type
allele. The near halving of Na,K-ATPase activity inMyk/mice
indicates that 3 is the functionally dominant Na,K-ATPase 
isoform in the young adult brain. In contrast, total brain Na,K-
ATPase activity in E18 fetuses was 44 3% inMyk/Myk and 66
5% in Myk/ relative to / littermates (Fig. 5), indicating more
significant contributions from 1 and 2 during development. No
functional phosphorylatable 3 Na,K-ATPase enzyme was ex-
pressed in the brains ofMyk/Myk fetuses, as indicated by the lack of
Na,K-ATPase phosphorylation from [-32P]ATP in brain ho-
mogenates under highMg2 conditions where the phosphorylation
of 2 is negligible (Fig. S7). Western blot analysis did not reveal
differences in 3 protein abundance in whole brain fromMyk/Myk
andMyk/ fetuses orMyk/ adults (Fig. 5), and immunocytochem-
ical analysis of cultured neocortical neurons demonstrated normal
membrane targeting of 3 over the surface of the soma and
processes and colocalization with agrin (Fig. 5), an endogenous 3
inhibitor that enhances membrane depolarization and increases
action potential frequency in cortical neurons (20). Thus, Myshkin
is functionally a null allele of Atp1a3 that encodes a normally
expressed, but inactive enzyme.
To further establish a causal link between theMyshkinmutation
and the observed phenotype, we performed a complementation
test for recessive perinatal lethality. Heterozygous Myshkin males
were crossed with female mice heterozygous for a point mutation
in Atp1a3 intron 4 (Atp1a3tm1Ling) that show reduced 3 expression
(21). No tm1Ling/Myk mice were detected among the 128 progeny
at 4 weeks of age. These results, together with the rescue of the
epileptic phenotype in the Myk//BAC mice (Figs. 2 and 3),
indicate that the Myshkin mutation is solely responsible for the
epileptic phenotype. Hence, we have shown that a loss-of-function
mutation of 3 Na,K-ATPase causes epilepsy in mice. In con-
trast, seizureswere not reported inAtp1a3tm1Ling/mice, even on the
relatively seizure-prone Black Swiss background (21, 22) rather
Fig. 2. Epileptic seizures in Myk/mice. (A) Spontaneous seizure in 16-week-
oldMyk/N2 B6 male. Frames 1–4 were captured at 4-s intervals after the loss of
postural control. (B) Electrocorticogram trace from Myk/mouse before (Prein-
duction) and after cage shaking (Postinduction). (C) Number of electrographic
seizures observed in/ (n 6), Myk/ (n 9, **, P 0.005), and Myk//BAC
(n 6) mice after cage shaking.








than the seizure-resistant B6 strain of Myshkin (23). However,
10-week-old tm1Ling/ mice displayed only a 16  4% reduction
in brain Na,K-ATPase activity, which is even less than the
modest reduction in seizure-resistant Myk//BAC mice (Fig. 5).
The tm1Ling/ mice showed a greatly reduced expression of the
pore forming NR1 subunit of the NMDA receptor (21), whilst
expression inMyk/mice was unaltered relative to/ littermates
(Fig. 5). Chronic over-stimulation of NMDA receptors is known to
induce seizures (18, 19). Hence, synergism between 3 Na,K-
ATPase and NMDA receptor activities may contribute to deter-
mine the epileptic propensity, possibly through disruption of cal-
cium metabolism.
There are several possibilities for explaining the observed link
between dysfunction of the neuronal 3-isoform of Na,K-
ATPase and hyperexcitability. The loss of 3 Na,K-ATPase
activity might induce neuronal membrane depolarization accom-
panied by hyperexcitability through an increase of the extracellular
K concentration because of the deficient clearance by the
Na,K-pump (4, 5). Although the 2-isoform of Na,K-ATPase
present in glial cells has been promoted as the major isoform
involved in K clearance, there are indications that neuronal
Na,K-ATPase could be more important than glial Na,K-
ATPase for K clearance after epileptiform activity induced in
hippocampal slices (8). Our finding that 3 is the functionally
dominant subunit in the adult brain is consistentwith the reported
lack of seizures in 1 or 2 heterozygous mice (21, 24). Reduced
3-mediated Na transport in neurons might furthermore lead to
a greater elevation in posttetanic intracellular Na with a concom-
itant reduction in Na/Ca2 exchanger-mediated calcium extru-
sion, and dysregulated calcium transients could lead to a rise of the
intracellular Ca2 level with accumulation of glutamate in the
synaptic cleft (6) and to over-activation of calcineurin and inter-
nalization of GABA receptors (25, 26).
Conclusion
We have characterized a mutation I810N that inactivates the
neuron-specific3-isoformofNa,K-ATPase and causes epilepsy
in mice. Because of the importance of ion homeostasis in main-
taining normal excitability, it is not surprising that Na,K-ATPase
function is implicated in the development of epileptiform activity.
Nevertheless, our study of mice with specific inactivation of the 3
isoform reveals the functional significance of the 3 isoform in the
Fig. 3. Reduced threshold for epileptiform activity inMyk/
mice. (A)Bright-field imageof transverse sliceofhippocampus
and entorhinal cortex (EC). Positions of the stimulating elec-
trode (S) and of the recording electrodes (R) are illustrated. (B)
Time to start of quasi rhythmic spiking after washout of ex-
tracellular Mg2 (*, P0.05,**, P0.005, t test). (C) Response
incidence for different types of epileptiform activity (illus-
trated in D and E) within 1 h of Mg2 washout. “Sync” refers
to the incidence of synchronized ictal bursts in EC and CA3
within 2 h of Mg2washout (**, P0.005,2-test). (D) Sample
sweeps illustrating repeating synchronized ictal bursts in
Myk/ slice.Belowis shownasingle ictalburstonanexpanded
time scale. (E) Typical sample sweeps from/ slice.
Fig. 4. Enhanced E-S coupling (popAP:fEPSP ratio) in
Myk/mice,25–55minafterTBS. (A)BeforeTBS, therelation
between the postsynaptic fEPSP slope in CA1 stratum radia-
tum and the popAP, measured at the same transverse loca-
tion in CA1 stratum pyramidal, did not differ between ge-
notypes (‘‘baseline’’, open symbols). After TBS, Myk/mice
exhibited a higher E-S coupling (popAP:fEPSP slope) than
/mice. (B) Summary of the E-S coupling data in A (*, P
0.001, **, P 10–9, #P 0.01).
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control of epileptogenesis and seizure behavior. Given the high
level of homology between the different Na,K-ATPase isoforms
ofmice and humans, our findings suggest that inactivatingmutation
of ATP1A3 is a candidate mechanism for human epilepsy, and
highlight 3 and its physiological regulators as putative targets for
the rational design of antiepileptic therapies.
Materials and Methods
Mice.AnimalprocedureswereapprovedbytheAnimalManagementCommittee
of Mount Sinai Hospital and were conducted in accordance with the require-
ments of the Ontario Animals for Research Act 1971 and the Canadian Council on
Animal Care. We backcrossed Myk/ mice to the C57BL/6NCr strain (National
Cancer Institute) for 12 generations before conducting phenotypic tests on
sex-balanced groups of Myk/ and/ N12 littermates at 10–14 weeks of age.
PCR-based genotyping assays for each mouse line are described in the SI Text.
Linkage Mapping and Positional Cloning. The meiotic linkage mapping and
positional cloning strategy that we used to identify the Myshkin mutation has
been described previously (14).
Na,K-ATPase Mutants Expressed in COS Cells. Using the QuikChange Site-
Directed Mutagenesis kit (Stratagene), mutations D65E, I810N, and the combi-
nation D65EI810N were introduced directly into full-length cDNA encoding an
ouabain resistant version of the human 3 isoform, which carried the mutations
Q108R and N119D to reduce the affinity for ouabain (27). To examine the
functionality of the mutant and wild-type ouabain resistant enzymes, the cDNAs
inserted in the expression vector pCMV6-XL-5 were transfected into COS-1 cells
grown in the presence of 5 M ouabain, which preferentially inhibits the
ouabain-sensitive Na,K-ATPase endogenously present in COS-1 cells (15).
Electrocorticography. Stereotactic implantation of electrodes and ECoG record-
ings were carried out on Myk/, Myk//BAC, and / mice, as described
previously (28).
Valproic Acid Treatment and Seizure Scoring. From weaning at 4 weeks of age,
Myk/mice were i.p. injected daily for 66 days with either sodium valproate (150
mg/kg; Sigma) dissolved in distilled water (n 13) or vehicle (n 10) in a volume
of 10 mL/kg body weight. The dose was determined by reference to a previous
study of C57BL/6 mice (29). Mice were placed in a clean cage 30 min after the last
injection. After a habituation period of 5 min, the cage was shaken for 30 s and
seizure behavior was observed for 2 min. Seizure behavior was quantified on a
1–6 scale using the following behavioral scoring system: 1, running; 2, staring; 3,
tail raise/vibrating; 4, small myoclonic jerk; 5, large myoclonic jerk (raising mouse
intotheair);6, tonic-clonic seizure.Thescoreassignedreflectedthehighestgrade
seizure behavior expressed by the mouse within the test.
BAC Transgenic Mice. MSMg01–344N17 BAC DNA of Mus musculus molossinus
origin was purified in a NucleoBond AX500 column (Machery-Nagel) and resus-
pended in polyamine microinjection buffer. BAC DNA was injected into the
pronucleus of (C57BL/6 SJL) F2 embryos, which were then transferred into the
oviducts of 0.5 day pseudopregnant CD-1 females (Charles River Laboratories).
From among the 154 pups born, 6 BAC transgenic pups were identified by PCR
amplification across the SP6 and T7 vector-insert boundaries and by the presence
of a BseYI (New England BioLabs) restriction site (ss60981659; 5-C*CCAGC-3).
Germline transmission and good breeding performance were established in 1
line.
In Vitro Electrophysiology. Myk/ and / mice (14–16 weeks old) were
decapitated under isoflurane anesthesia and their brains isolated in ice-cold
artificial cerebrospinal fluid (aCSF) containing (in mM): 124 NaCl, 26 NaHCO3,
Fig. 5. Mutational and BAC transgenesis effects on
Na,K-ATPase activity and 3 expression in brain. (A) Spe-
cific Na,K-ATPase activity in brain homogenates of 10-
week-old Myk/ (n 6) and tm1Ling/mice (n 4) and of
Myk/ (n  11) and Myk/Myk E18 fetuses (n  5) (mean 
SEM). Results are expressed as a % of / littermate levels
(adultsn6, fetusesn7).**, P0.01;***, P0.001;****,
P  0.0001 versus respective / littermates; ###P  0.001
versus tm1Ling/mice. (B) Specific Na,K-ATPase activity in
brain homogenates of 10-week-oldMyk/ (n 4) andMyk/
/BAC (n 4) mice (mean SEM). Results are expressed as
a % of/ littermate levels. **, P0.01 versusMyk/mice;
####P  0.0001 versus / mice. (C) Typical blots of 20 g
protein from brains probed with anti- Na,K-ATPase 3,
anti-NR1, and anti--tubulin III antibodies (Left). Immunore-
activity of Myk/Myk (n  4) and Myk/ (n  6) E18 fetus
brains and Myk/ (n  8) adult brains expressed as a per-
centage of/ (E18 n 4; adult n 8) levels (Right). Each
sample was blotted 3 times, and -tubulin III was used as
loading control. *, P  0.05 versus / E18 fetus brains
(Right). (D) Distribution and signal intensity of 3 (Red) and
agrin (Green) in cultured neocortical neurons from E18 fe-
tuses (Left). (Scale bar, 24m.) Colocalization coefficients for
Myk/Myk (n 14) and/ (n 14) E18 fetuses (Right).








3 KCl, 2 CaCl2, 2 MgCl2, 26 NaHCO3, 1.2 NaH2PO4, and 10 glucose. For exper-
iments employing hippocampal slices, whole hippocampi were isolated, sliced
at 400 m on a manual chopper (Stoelting), and maintained as described
previously (30). Methods for studies of in vitro epilepsy are described in the SI
Text.
Magnetic Resonance Imaging. Magnetic resonance imaging was conducted as
described previously (31).
ElectronMicroscopy. Electron microscopy was conducted as described previously
(32).
Na,K-ATPase Functional Assays of Brain Homogenates. Brain tissue was
homogenized in a buffer containing 85 mM NaCl, 20 mM KCl, 4 mM MgCl2, 0.2
mM EGTA, 30 mM histidine (pH 7.2), and 10% sucrose (wt/vol), and was further
permeabilized by incubation with 0.65 mg sodium deoxycholate/mL at a total
brain protein concentration of 0.3 mg/mL in the presence of 2 mM EDTA and 2
mM imidazole at 20°C. The ouabain sensitive Na- and K-activated ATP hydro-
lysis rate was determined at 37°C by a colorimetric assay for liberated Pi (15). The
deoxycholate treated brain tissue homogenate (25 L) was added to 500 L
ATPase buffer containing 30 mM histidine (pH 7.5), 140 mM NaCl, 20 mM KCl, 3
mM MgCl2, and 1 mM EGTA, and was allowed to react for 5 min with 3 mM ATP
in the presence and absence of 3 mM ouabain. When the Na concentration was
varied, the K concentration was kept at 20 mM, and when the K concentration
was varied, the Na concentration was kept at 40 mM. The Na,K-ATPase active
site concentration was determined by phosphorylation at 0°C in the presence of
2M[-32P]ATP,20mMTris (pH7.5), 3mMMgCl2,150mMNaCl,1mMEGTA,and
oligomycin (20 g/mL) to inhibit dephosphorylation, and the catalytic turnover
rate was calculated as the ratio between the ATPase activity and the active site
concentration. In some experiments, the phosphorylation level was also deter-
minedathigherMg2concentrationsbutunderotherwisesimilarconditions.The
phosphoenzyme was quantified using the Packard Cyclone storage phosphor
system after acid quenching, washing by centrifugation and SDS-polyacrylamide
gel electrophoresis at pH 6.0. The background phosphorylation determined in
the presence of 50 mM KCl without NaCl was subtracted.
Protein Extraction and Blot Analysis. Whole brain homogenates fromMyk/Myk,
Myk/ and/ E18 fetuses and from 12-week-oldMyk/,/ andMyk//BAC
mice were subjected to SDS/PAGE followed by blotting and visualization with
goat anti-Na,K-ATPase 3 (sc-16052; Santa Cruz; 1:100) or rabbit anti-NR1
(06–311; Upstate; 1:1,000). Immune complexes were detected by chemilumines-
cence (ECL Western blotting detection reagents, GE Healthcare). Plasma mem-
brane and ER fractions of COS-1 cells transiently expressing transfected WT and
mutant Na,K-ATPase were isolated by differential centrifugation according to
procedures described previously (15, 33), and subjected to SDS/PAGE followed by
blotting and visualization with anti-Na,K-ATPase 3 mouse monoclonal pri-
mary antibody (A-273; Sigma) and HRP-conjugated goat anti-mouse IgG second-
ary antibody.
Immunocytochemistry. Neocortical neuron cultures were prepared from E18
embryos, as described previously (34), and subjected to immunostaining with
rabbit anti-Na/K-ATPase 3 (06–172; Upstate; 1:1,000) or mouse anti-agrin
(AGR-131; Novus; 1:500) primary antibodies.
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